Kaneka Corporation has announced the commencement of European sales for its i-ED COIL™, a brain aneurysm embolization coil, following the receipt of EC certification under the EU Medical Device Regulation (MDR) in July 2025. Distributed primarily through Kaneka Medical Europe N.V., the i-ED COIL™ is engineered with world-class flexibility enabled by its specialized wire thickness and structure, allowing denser packing within aneurysms and effective treatment of irregularly shaped cases. Since launching in Japan in 2019, the device has received strong support from doctors. It helps lower the risk of aneurysm rupture and has steadily increased sales.
Also Read: Shippeo Launches Shippeo AI for Smarter Supply Chain Visibility
Kaneka’s expansion into Europe is key to growing its global medical device business. This includes devices for cardiac, peripheral vascular, cerebrovascular, and gastrointestinal treatments. The company aims to achieve 300 billion yen in sales by 2030. This goal will come from its Health Care Solution Unit and global product expansion. Guided by its corporate mission, “KANEKA thinks ‘Wellness First,’” the company seeks to make advanced medical care universally accessible while advancing scientific innovation for healthier lives and a sustainable global environment.